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Purpose: To screen a cohort of corneal dystrophy patients from North India for mutations in the transforming growth
factor beta induced (TGFBI) gene, to correlate genotypes to phenotypes, to describe structural implications of various
mutations on protein function, and to discuss the implications for diagnosis.
Methods: Eighty affected individuals from 61 unrelated families, who were diagnosed with autosomal dominant granular
and/or lattice corneal dystrophy, were recruited for the study. Detailed clinical evaluation was undertaken for these patients
to establish their corneal phenotypes. Genomic DNA was isolated from peripheral blood samples and all exons of
TGFBI were screened for mutations by polymerase chain reaction (PCR) and direct DNA sequencing. Protein molecular
dynamics (MD) simulations were performed for the mutations detected to assess the changes in protein structure.
Results:  The  most  common  mutations  seen  were  Arg555Trp  and  Arg124Cys.  Two  novel  mutations,  Ser516Arg
(c.DNA1548C>G), with a phenotype similar to granular corneal dystrophy I (GCDI), and Leu559Val (c.DNA1675T>G),
with an atypical phenotype closely resembling epithelial basement membrane dystrophy/map dot fingerprint dystrophy,
were identified. Protein modeling studies involving wild type and mutant protein indicated that the Leu559Val is a
destabilizing mutation and that Ser516Arg could adversely affect the specific binding of Fas1 domain 4 with other proteins.
In addition, two single-nucleotide polymorphisms, rs4669 and rs11331170, were also identified. Mutations were not
identified in 8 affected individuals, 6 of whom were diagnosed with bowman layer dystrophy and 2 with lattice corneal
dystrophy.
Conclusions: This is the first comprehensive report of TGFBI mutations covering a large part of North India. Identification
of novel mutations, the presence of phenotypic variability, and the genetic heterogeneity seen in our cases stress the need
for mandatory screening of TGFBI for precise diagnosis and classification of corneal dystrophies.
Corneal  dystrophies  (CDs)  are  defined  as  a  group  of
inherited,  bilateral,  symmetric,  slowly  progressive  corneal
diseases  without  any  relationship  to  environmental  or
systemic factors. Recently, the International Committee for
Classification of Corneal dystrophies (IC3D) has provided a
new  classification  that  integrates  phenotypic  description,
histopathological examination, and genetic analysis [1]. Since
the initial discovery by Munier et al. [2] of mutations in the
transforming growth factor beta induced gene (TGFBI; also
known as BIGH3), located on chromosome 5q31 that cause
autosomal dominant CDs, more than 38 mutations have been
reported in association with different phenotypic variants [1,
3-5]. Specific mutations in TGFBI are associated with distinct
forms of CDs although both interfamilial and intrafamilial
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variability  have  been  described  in  patients  belonging  to
different ethnic backgrounds [6].
TGFBI  codes  for  an  extracellular  matrix  protein,
keratoepithelin. The protein has 683 amino acids and four
internal  repeat  domains,  with  structural  homology  to
fasciclin-1 of Drosophila [7]. The gene is expressed in many
tissues, including corneal epithelium, and its mutations in this
tissue  lead  to  accumulation  of  abnormal  keratoepithelin
protein [8]. Keratoepithelin was initially discovered as a 69-
kDa secretory protein in a human lung adenocarcinoma cell
line [9]. The protein includes an NH2-terminal signal peptide
that is excised during export to the extracellular matrix, four
fasciclin-like domains, and a COOH-terminal Arg-Gly-Asp
(RGD) sequence, which is a putative integrin-binding motif.
Keratoepithelin has been suggested to bind to integrins,
which  are  cell  surface  receptors  that  trigger  downstream
signaling [10-12], as well as to different types of collagens
[13,14].
Four distinct autosomal dominant corneal dystrophies are
associated with mutations in TGFBI; these include granular
CD type I, granular CD type II (Avellino), granular CD type
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1429III (Reis- Bücklers dystrophy), and Lattice CD (LCD). Of
these, Groenouw granular CD I (CDGG1, OMIM 121900) is
the  most  common  type  of  autosomal  dominant  corneal
dystrophy and is characterized by the presence of multiple
discrete  crumb-like,  gray-white  corneal  opacities  [15].
Histopathologically, these opacities stain red with Masson
trichrome  [16].  Typical  granular  corneal  dystrophy,  i.e.,
GCDI is caused by an Arg555Trp mutation [2]. The LCD
(OMIM 122200) form is characterized by fine, refractile lines
that form a branching network [17]. On histopathology, the
deposits in LCD stain positively with Congo red and are
birefringent under polarized light. Various subtypes (I, IIIA,
I/IIIA, IIIB, and IV) of LCD occur, with classification based
on the underlying mutations in the TGFBI.
The present study, conducted on eighty individuals, was
aimed at identification of the underlying mutations in the
autosomal dominant granular or lattice CDs. We report, for
the first time, the mutation spectrum of patients encompassing
the population in a major part of North India.
METHODS
The study protocol adhered to the tenets of Declaration of
Helsinki and was approved by the Ethics Committee of the
Institute (All India Institute of Medical Sciences, AIIMS). The
patients presented at the Cornea Clinic of the Dr. Rajendra
Prasad Center for Ophthalmic Sciences, AIIMS, New Delhi,
India). All CDs were diagnosed by clinical evaluations and by
histopathological  evidence  wherever  possible.  Clinical
examination  included  routine  slit  lamp  biomicroscopy,
confocal microscopy, and specular microscopy. All patients
who were bilaterally affected and who did not have any other
systemic involvement formed the study group.
A total of 80 patients from 61unrelated families were
recruited after obtaining their informed consent. Of these 80
patients, 51 (64%) were clinically diagnosed with granular
CD, 23 (29%) were diagnosed with lattice CD, whereas in six
(7.0%) patients the subtype of CD could not be ascertained
based on the clinical features. Detailed family history was
collected and pedigree charts were constructed for all patients.
The control population consisted of 100 unrelated and
healthy individuals who had no history of any ocular disease
in their family. From both groups – the controls and patients,
along with their available family members – 5 ml samples of
peripheral  blood  were  collected  in  EDTA  after  obtaining
informed consent.
Histopathological  data  were  available  for  correlation
with clinical diagnosis in seventeen patients who underwent
surgical intervention (keratoplasty). For histopathology, the
corneal  sections  were  processed  by  standard  methods
involving sectioning of the tissue samples; sections were then
stained  with  Congo  red  and/or  Masson  trichrome  and
analyzed by light microscopy for the presence of amyloid and/
or hyaline deposits. The presence of amyloid was confirmed
by birefringence when viewed under polarized light.
The  peripheral  blood  samples  were  processed  for
Genomic  DNA  extraction  using  DNAeasy  kits  (Qiagen,
GmBH,  Hilden,  Germany).  These  samples  were  used  for
amplification of all 17 exons of TGFBI using primers and
conditions as described previously [2]. Briefly, the cycling
conditions were 5 min initial denaturation at 95 °C, 30 cycles
of 94 °C for 1 min, 58 °C/55°C for 1 min, 72 °C for 1 min,
and a final extension at 72 °C for 5 min. The reaction mixture
of 25 μl was prepared using 200 ng genomic DNA, primers
(0.5  µM  each),  MgCl2  (1.5  mM),  deoxyribonucleotide
triphosphates (dNTPs; 0.2 mM), 1× PCR buffer (containing
10 mM TRIS-HCl, pH 8.3, 50 mM KCl; Roche, Applied
Biosystems, Foster City, CA), and Taq polymerase (0.5 U;
Roche,  Applied  Biosystems).  Primer  sequences  used  for
amplification  are  listed  in  Table  1.  The  amplified  PCR
products were subjected to gel purification using QIAmp gel
extraction  kits  (Qiagen,  GmBH)  and  the  purified  PCR
products were screened for sequence changes by bidirectional
sequencing.  Sequencing  was  performed  using  BigDye
Terminator Mix, version 3.1 (Applied Biosystems, Inc. [ABI],
Foster City, CA) and were then analyzed on an ABI-3100
Genetic  Analyzer  (ABI).  Nucleotide  sequences  were
compared with the published sequence of TGFBI (GenBank
NM_000358) for analysis of sequence changes.
The crystal structure of the Fas1 domain 4 (amino acid
residues  502–633)  of  the  transforming  growth  factor-beta
induced protein, Big-H3, available in a public database (PDB
Id: 2VXP), was used as the starting point for all the molecular
modeling studies. Mutants (Ser516Arg and Leu559Val) were
generated  by  altering  the  corresponding  residues  and  the
resulting  native  and  mutated  structures  were  minimized
separately  by  employing  molecular  dynamics  simulation
protocols using the program Discovery Studio 2.0 (Messrs
Accelrys, San Diego, CA).
Molecular dynamics (MD) simulation: The effect of the
mutation on the overall conformation of the Fas1 domain 4 of
TGFBI was checked by extensive MD simulations performed
on a fully hydrated model of both the wild type and mutant
structures, using an explicit spherical boundary with harmonic
restraint with a Radius of Sphere as 25.0 Å (angstrom). The
Standard Dynamics Cascade Protocol was used with a time
step  of  one  femtosecond  (fs).  The  first  step  in  the  MD
simulation  was  the  energy  minimization  of  the  hydrated
model. The minimized hydrated complex was then subjected
to a MD simulation in three stages. In the first stage, the
temperature of the system was raised from 50 to 300 K over
2 picoseconds (ps), followed by equilibration for 20 ps, and
the final production run was performed for 0.5 ns (ns). The
conformations obtained after every 0.1 ns were saved and
analyzed  for  the  variations  induced  in  the  protein
conformation due to the mutations. To analyze the probable
quaternary  structures  (assemblies)  formed  by  this  protein,
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to the PISA server.
RESULTS
Of the total patients studied, 55% were females and 45% were
males. Most patients reported CD with an age at onset in their
second decade. Consanguinity was not seen in any of the
families. Seven patients with lattice CD and 15 with granular
CD had a positive family history of the disease. Mutations
Arg124Cys and Arg555Trp were the ones most commonly
seen in most the patients. The Arg555Trp mutation was seen
in  35  patients  (44%)  with  GCD  I  and  19  patients  (24%)
showed  typical  lattice  CD  (LCDI)  with  an  underlying
Arg124Cys mutation. The other changes observed included
two  novel  mutations,  Ser516Arg  (c.DNA1548C>G)  and
Leu559Val  (c.DNA1675T>G),  in  patients  clinically
characterized to have granular CD and a variant of granular
CD/epithelial basement membrane dystrophy, respectively.
Pedigrees  with  segregation  of  the  novel  mutations  in  the
available family members are shown in Figure 1 and Figure
2.
Mutations  Thr538Pro  and  Arg124His  have  been
identified for the first time in a population from India. Other
reported  mutations  identified  include  Arg124Leu,
His626Arg, and Ala546Asp and the phenotypes of the patients
conformed to those reported earlier (Table 2). In addition, we
also identified two single nucleotide polymorphisms, rs4669
and rs11331170, in the TGFBI gene. All of these mutations
were present in the heterozygous state in the probands and
were absent in 100 unrelated unaffected individuals of the
control group, based on direct sequencing.
Of the eighty cases, TGFBI mutations were not identified
in 8 patients. Of these 8 cases, 6 were clinically diagnosed to
have bowman layer dystrophy and 2 had lattice CD.
Clinical and histopathological features of patients with novel
mutations:
Clinical details—The proband (Figure 1A), a 19 year old
male, had multiple small discrete opacities in the anterior
stroma with clear intervening stroma and limbus. (Figure 1B)
The patient had no photophobia or corneal erosions. His best
corrected visual acuity was 6/12 in both eyes. He had suffered
a diminution of vision since the age of 11 years. Corneal
pachymetry revealed normal thickness (496 [right eye]; 490
[left eye]). Specular microscopy revealed a normal endothelial
cell count in both eyes (2,886 [right eye], 2,941 [left eye]).
His 17-year-old brother and his 46-year-old mother were also
affected and had a similar phenotype. The deep stroma of all
of the affected family members was clear and only the anterior
stroma  was  affected.  No  surgical  interventions  were
undertaken in view of the good visual acuity of the patient.
Mutation  analysis—Direct  sequencing  analysis  of
TGFBI revealed an underlying change in exon 12 at codon
516 with the amino acid serine being replaced by arginine
(Ser516Arg; Figure 1C). The mutation was present in the
heterozygous state in the proband and segregated in all of the
affected  family  members  and  in  none  of  the  unaffected
members of the family. The previously reported SNP rs4669
was also identified in all the affected members of the family.
This  mutation  was  absent  in  100  controls  who  were  also
screened for underlying changes by direct sequencing.
Protein  modeling—A  comparison  of  the  MD
conformers in the mutants Ser516Arg and wild type structures
revealed a minor variation in the overall geometry of the
protein, with a root mean square deviation (rmsd) variation of
0.7 Å for Ser516Arg in the backbone atoms. The stability of
the  protein  was  conserved  even  in  the  presence  of  the
Ser516Arg  mutation.  Closer  analysis  revealed  a  subtle
deviation in the secondary structure element, mainly in the
regions housing the mutant and its neighboring interacting
TABLE 1. TABLE SHOWING THE TGFBI PRIMER SEQUENCES.
Sample
number Exon Forward primer Reverse primer
Product size
(base pairs)
Annealing
temp (°C)
1 1 5’-CCGCTCGCAGCTTACTTAAC-3’ 5’-AGCGCTCCATGCTGCAAGGT-3’ 360 58
2 2 5’-GTGGACGTGCTGATCATCTT-3’ 5’-TCCTGGCTGGTTACAGATAC-3’ 170 55
3 3 5’-GAGAATGCCATGTCCTTGTG-3’ 5’-GCTGTGGAGGCAACTTAGTG-3’ 280 58
4 4 5’-CCCCAGAGGCCATCCCTCCT-3’ 5’-CCGGGCAGAAGGAGGTCATC-3’ 225 55
5 5 5’-TAAACACAGAGTCTGCAGCC-3’ 5’-TTCATTATGCACCAAGGGCC-3’ 260 55
6 6 5’-TGTGTTGACTGCTCATTCTT-3’ 5’-CATTCAGGGGAACCTGCTCT-3’ 316 55
7 7 5’-AAGTGTGCCAAGTTGACCTC-3’ 5’-GGCAGGTGGTATGTTCATCT-3’ 588 55
8 8 5’-AGAAGGCGAGGAGGATCTGG-3’ 5’-CAGTGGCCGAGAAGCTGTGA-3’ 508 55
9 9 5’-CATTCCTGCTGATGTGTGTCATGC-3’ 5’-GGGTGCTGTAAATCGGAGAGTGTT-3’ 315 55
10 10 5’-TCTGGACCTAACCATCACCC-3’ 5’-CAGGAGCATGATTAGGACC-3’ 206 55
11 11 5’-CTCGTGGGAGTATAACCAGT-3’ 5’-TGGGCAGAAGCTCCACCCGG-3’ 223 55
12 12 5’-CATTCCAGTGGCCTGGACTCTACTATC-3’ 5’-GGGGCCCTGAGGGATCACTACTT-3’ 318 55
13 13 5’-CCTCCTTGACCAGGCTAATTA-3’ 5’-GGCTGCACTGAAGGTTGTG-3’ 300 55
14 14 5’-CTGTTCAGTAAAACTTGCT-3’ 5’-CTCTCCACCAACTGCCACAT-3’ 260 58
15 15 5’-ACAGCATCTCACCTCAGTGT-3’ 5’-AACCTAGCAGGCATCTTACC-3’ 360 55
16 16 5’-GCTTGCACAACTTATGTCTG-3’ 5’-CAGGTCTGCAATGACTTC-3’ 251 55
17 17 5’-CCTGTCCTTGAGATTCTGA-3’ 5’-GAGGCTGGATTGCTTGATTC 489 55
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Family 1 - Mutation S5156R:residues, which comprised the secondary sites at amino acid
positions 505–511, 544–550 and 516–525 (Figure 1D).
The mutation of Ser516 alters the characteristic of the
residue in terms of both the nature and the length of the side
chain. The longer and basic arginine residue in the mutated
TGFBI forms an additional hydrogen bond with the side chain
of Asn513, whereas in the wild type, Ser516 formed bonds
with  the  asparagine  (Asn544)  side  chain,  resulting  in
shortening of the helical conformation in the mutated protein.
Due to the change in the interacting residues, a subtle change
in the conformation of the loops involving residues 513 and
544 was also observed. The PISA server analysis shows that
mutation results in an overall gain in solvation free energy of
the protein molecule. The solvation free energy is the amount
of energy released when two protein molecules interact and is
an indicator of the possibility of interactions between two
protein molecules. Thus, the increase in energy indicates that
due to the mutation Ser516Arg, the interaction of the present
protein with other proteins is affected.
Family 2 – Mutation L559V:
Clinical details—Slit lamp examination of a 42-year-old
female patient (Figure 2A) revealed map-like opacity in the
Figure 1. Family 1, showing the S516R mutation in the transforming growth factor beta Induced (TGFBI) gene. A: Pedigree of the family.
Filled boxes represent affected individuals. Open boxes represent unaffected individuals. Arrowhead indicates the proband. Filled circle with
a slash indicates a deceased individual. B: Slit lamp photomicrograph of the affected individual. The representative clinical photograph shows
the presence of discrete gray-white deposits in the right eye of the proband, with clear intervening stroma resembling granular corneal
dystrophy. C: Partial nucleotide sequence of the transforming growth factor beta induced (TGFBI) gene. The chromatogram of the patient (P)
is shown compared to a control (C). A heterozygous C>G substitution, marked by the arrowhead, is shown. The black box denotes the nucleotide
that causes the missense mutation resulting in amino acid substitution of the Serine (S) at amino acid position 516 with Arginine (R). The
partially dashed blue line at the top left of the chromatogram marks the intronic region, while the red line on the right marks the start of the
exon. D: Protein modeling in S516R mutation showing the superimposition of S516R mutant (yellow) and wild type conformers (cyan). Only
the mutant structures, where the deviations were observed, are shown in the figure. The conformational changes in the secondary structure
elements are shown for amino acid residues 505–511 (A), 516–525 (B) and 544–550 (C). The changes observed in molecular interactions
(Hydrogen bonds) are also marked by dashed lines.
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1432Figure 2. Family 2 showing the L559V mutation in the transforming growth factor beta induced (TGFBI) gene. A: Pedigree of the family.
Filled boxes represent affected individuals. Open boxes represent unaffected individuals. Arrowhead indicates the proband. Gray boxes mark
the affected individuals with a variable phenotype. B-E: Slit lamp and in-vivo confocal photomicrographs of the affected individual. The
representative clinical photographs of the proband show the presence of a map-like structure in the right eye (B). Retro illumination
photomicrograph demonstrates a fingerprint-like pattern in the right eye (C). The left eye of the proband shows multiple dot-like opacities
(D). The map pattern in the sub-epithelial region, which was confirmed by in vivo confocal microscopy, is shown (2E). F: Partial nucleotide
sequence of the transforming growth factor beta induced (TGFBI) gene. The chromatogram of the patient (P) is shown compared to a control
(C). A heterozygous T>G substitution, marked by the arrowhead, is shown. The block denotes the nucleotide with missense mutation that
results in amino acid substitution of Leucine at 559 position with Valine. The partially dashed blue line on the top right of the chromatogram
marks the start of intron while the red line marks the exonic region. G-H: Representative slit lamp photomicrographs of the affected family
member. Representative clinical photographs of the affected family member (G) showing very fine dot like opacities in the right eye. The
indirect slit lamp retroillumination image (H) shows the presence of multiple dimple-like structures in the affected cornea.
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1434inferonasal quadrant of the cornea (almost adjacent to the
pupillary area) in the right eye (Figure 2B,C). The left eye of
the  patient  had  multiple  dot-like  white  opacities  in  the
inferonasal quadrant overlying the pupillary areas (Figure
2D). The presence of map-like opacities in the right eye was
confirmed by in-vivo confocal microscopy (Figure 2E). The
epithelium of both eyes had a beaten metal appearance. Her
uncorrected  visual  acuity  was  6/18  in  both  eyes.  Genetic
analysis identified a missense mutation whereby the amino
acid  leucine  at  position  559  was  replaced  with  valine
(Leu559Val; Figure 2F). Examination of all members of the
family  identified  the  mother  and  one  brother  as  affected,
although neither reported any visual complaints. The visual
acuity of the brother, who was 40 years old at the time of
examination, was 6/6 in both eyes. The mother, aged 68 years,
had best corrected visual acuity of 6/12 in both eyes. Slit lamp
examinations identified dot-like opacities in both the mother
and the affected brother (Figure 2G,H). The same Leu559Val
mutation was identified in the mother and the brother, while
none of the unaffected family members or any of the 100
controls showed this change.
Protein  modeling—A  comparison  of  the  MD
conformers in the mutants L559V and wild type structures
revealed minor variation in the overall geometry of the protein
with an rmsd variation of 0.9 Å for Leu559Val in the backbone
atoms, which was checked with the ProsaII server [18]. The
stability of the protein and odds of misfolding in the mutant
structures was checked with the Eris server [19]. The overall
geometry  of  the  Leu559Val  mutant  conformers  was
conserved;  however,  the  protein  stability  calculations
suggested that this mutation had resulted in loss of protein
stability.  A  minor  difference  in  the  secondary  structure
elements, mainly in the regions in and around the mutated
residues, was also observed (Figure 3).
DISCUSSION
Mutational  analysis  of  the  80  patients  from  North  India
revealed typical missense mutations in exon 4 (Arg124Cys)
and exon 12 (Arg555Trp) of TGFBI in most the patients with
lattice  corneal  dystrophy  (LCD)  and  granular  corneal
dystrophy (GCD), respectively. This work represents the first
report of mutations Arg124His and Thr538Pro from India.
Two  novel  mutations,  Ser516Arg  and  Leu559Val,  were
identified in patients who were clinically diagnosed with GCD
and an atypical variant of GCD, respectively. Both mutations
occur in the highly conserved fourth fasciclin like domain of
keratoepithelin. These positions are well conserved among the
orthologs,  like  Mus  musculus,  Xenopus  laevis,  Tetradon
nigrovirdis, etc., when evolutionary comparisons were made
using the SIFT (Sorting Intolerant From Tolerant) tool (Figure
4A,B).
The  phenotype  of  the  two  siblings  with  Ser516Arg
resembled that of granular corneal dystrophy I (GCDI). These
patients did not undergo any surgical intervention due to their
good visual acuity. Hence, histopathology was not performed
to confirm the nature of the deposits in these patients. In a
recent report on Chinese families, two novel mutations at
positions  Arg514Pro  and  Phe515Leu  were  identified  in
TGFBI with phenotypes resembling LCD [20]. We identified
a  mutation  in  the  adjacent  amino  acid  with  a  phenotype
resembling GCD. The two previously described mutations
(Arg514Pro and Phe515Leu) occur in exon 11 of the TGFBI
Figure  3.  :  Protein  modeling  studies
showing the superimposition image of
L559V mutant (yellow) and wild type
conformers  (cyan).  Only  the  mutant
structures  in  which  deviations  were
observed  are  shown.  The
conformational  changes  in  the
secondary  structure  elements  are
marked for the amino acid residues 544–
549 (A), 552–560 (B) and 563–572 (C),
respectively. The changes were mainly
observed in non-covalent hydrophobic
interactions.
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1435gene, while the mutation Ser516Arg seen in our Family 1
occurs in the first nucleotide of exon 12. This change in the
first  nucleotide  of  exon  12  might  affect  the  pre-mRNA
splicing, leading to either exon skipping or intron retention,
which  would  consequently  result  in  an  altered  protein
structure. This may be a possible reason for the different
phenotype seen in our family when compared to the changes
at the adjacent codons that gave rise to the lattice-like features
reported by Zhong et al. [20].
Earlier molecular modeling and mutational studies on the
Fas1 domain 4 of the corneal protein TGFBI suggested that
the  mutation  Ser516Arg  is  part  of  the  predominant
hydrophobic groove (F515-L531) and is present on the outer
surface of the protein (Figure 5), which had a role in protein–
protein  interaction  [8].  Protein  modeling  of  Ser516Arg
mutation  revealed  that  the  change  decreases  the
hydrophobicity which is required for specific protein affinity.
This adversely affects its association and specific binding
interactions with that of other proteins or its longer side chain
could possibly interfere with protein secretion.
The patient with the Leu559Val mutation had a map
pattern with fingerprint-like structures in the sub-epithelial
region,  in  addition  to  granular  gray-white  opacities.  This
phenotype did not conform to typical GCD or its subtypes, as
seen in Figure 2. The affected mother and brother did not
complain of any ocular problems, but harbored small dot-like
opacities  that  did  not  affect  their  visual  acuity.  A  highly
variable phenotypic presentation was seen for the Leu559Val
mutation in the affected members of Family 2. Mutation at the
adjacent amino acid leucine (Leu558Pro) caused an atypical
phenotype characterized as amyloid on histopathology [3].
None of the patients identified with the Leu559Val mutation
in  the  present  study  required  any  surgical  intervention;
therefore, the nature of deposits could not be ascertained on
histopathology.  Molecular  modeling  studies  on  the
Leu559Val mutant of TGFBI have shown that this mutant has
Figure 4. Multiple sequence alignment
of the transforming growth factor beta
induced  (TGFBI)  gene  from  different
species. A: The amino acid Serine (S) at
position  516,  conserved  in  all  of  the
orthologs, is highlighted in red. B: The
amino acid Leucine (L) at position 559,
highlighted in red, is conserved during
the  course  of  evolution  over  a  large
range of species.
Figure 5. The quaternary association of
S516R  mutant  (cyan)  and  wild  type
(dark  blue)  structures  in  surface
representation,  as  obtained  using  the
Pisa  server.  The  mutation  is  colored
yellow and the interacting hydrophobic
groove  in  the  mutant  is  colored  red,
while the respective interacting surface
of the wild type structure is shown in
green.
Molecular Vision 2010; 16:1429-1438 <http://www.molvis.org/molvis/v16/a156> © 2010 Molecular Vision
1436minor  changes  in  the  secondary  structure  that  affect  the
stability of the protein. The mutation Leu559Val occurs in the
fourth  domain  of  keratoepithelin;  previous  studies  have
shown that mutations in the fourth domain alter the structure
of the protein, leading to its accumulation [8].
The cases harboring the novel mutations identified in the
present study underline the fact that phenotypic presentation
of the disease can be highly variable and can overlap. This
also highlights the fact that a single nucleotide change leading
to  an  amino  acid  substitution  alters  the  structure  of
keratoepithelin, leading to a difference in the nature of its
deposition and its accumulation pattern.
To  the  best  of  our  knowledge,  this  is  the  first
comprehensive  report  of  CDs  in  a  patient  population
encompassing a large part of North India. Such cases, with
phenotypic variability among the autosomal dominant CDs,
add to the difficulties in their classification, especially in cases
where no histopathological evidence is available. With no
underlying  mutation  seen  in  eight  cases,  our  study  also
supports the presence of genetic heterogeneity of the disease,
as reported earlier [21,22].
In conclusion, the study identified two novel mutations
that  add  to  the  existing  mutation  spectrum  of  the  TGFBI
dystrophies.  Our  results  reiterate  the  need  for  TGFBI
screening  as  an  essential  requisite,  along  with
histopathological  evidence  wherever  possible,  for  precise
diagnosis and classification of these dystrophies. This would
aid  in  the  proper  treatment,  management,  and  genetic
counseling of CD patients.
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